<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02732262</url>
  </required_header>
  <id_info>
    <org_study_id>JHSeo-Oxynorm</org_study_id>
    <nct_id>NCT02732262</nct_id>
  </id_info>
  <brief_title>Optimal Dose of i.v Oxycodone for Postoperative Pain</brief_title>
  <official_title>Optimal Dose of i.v Oxycodone for Postoperative Pain After Laparoscopic Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pain control is required after major abdominal surgery, including laparoscopic
      colorectal surgery. Intravenous oxycodone is widely used for postoperative acute pain control
      mainly in Europe.

      The aim of this study is to evaluate the optimal dose of intravenous oxycodone for pain
      control after laparoscopic colorectal surgery in Korean.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oxycodone is known to be effective in pain control and has less sedative effect than morphine
      does. It has been described that distribution of cytochrome P450, which is associated with
      metabolism of oxycodone, differed between the races. Proper dose of intravenous oxycodone
      after major abdominal surgery has not been well defined in Korean. The purpose of this study
      is to evaluate the optimal dose of intravenous oxycodone for pain control after laparoscopic
      colorectal surgery in Korean based on pain score and side effects.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resting postoperative pain at 24hr</measure>
    <time_frame>24 hr after surgery</time_frame>
    <description>Primary outcome is resting postoperative pain at 24 hr after surgery with numeric rating scale 010.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>24 hr after surgery</time_frame>
    <description>Secondary outcome includes any side effect at 24 hr after surgery.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Sedation</measure>
    <time_frame>24 hr after surgery</time_frame>
    <description>sedation with Ramsay sedation score (1-6) at 24 hr after surgery</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Oxycodone, 1.00 mg dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Regimen of intravenous patientcontrolled analgesia consists of bolus dose of oxycodone 1.00 mg with lock out time of 10 min without basal infusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone, 0.03 mg/kg dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Regimen of intravenous patientcontrolled analgesia consists of bolus dose of oxycodone 0.03 mg/kg with lock out time of 10 min without basal infusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone, 0.02 mg/kg dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Regimen of intravenous patientcontrolled analgesia consists of bolus dose of oxycodone 0.02 mg/kg with lock out time of 10 min without basal infusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone, 1.00 mg dose</intervention_name>
    <description>Intravenous oxycodone is provided as patientcontrolled analgesia after surgery with bolus dose of 1.00 mg.</description>
    <arm_group_label>Oxycodone, 1.00 mg dose</arm_group_label>
    <other_name>OxyNorm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone, 0.03 mg/kg dose</intervention_name>
    <description>Intravenous oxycodone is provided as patientcontrolled analgesia after surgery with bolus dose of 0.03 mg/kg.</description>
    <arm_group_label>Oxycodone, 0.03 mg/kg dose</arm_group_label>
    <other_name>OxyNorm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone, 0.02 mg/kg dose</intervention_name>
    <description>Intravenous oxycodone is provided as patientcontrolled analgesia after surgery with bolus dose of 0.02 mg/kg.</description>
    <arm_group_label>Oxycodone, 0.02 mg/kg dose</arm_group_label>
    <other_name>OxyNorm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists class 1, 2

          -  Expected surgical time between 2~ 6hours

          -  Scheduled for laparoscopic colorectal surgery

        Exclusion Criteria:

          -  Severe dysfunction of liver, heart, kidney, or lung

          -  Cannot understand numeric rating scale of pain

          -  Known or suspected allergy to oxycodone

          -  Previous history of postoperative nausea or vomiting

          -  Medication of antidepressants

          -  Postoperative longterm

          -  ICU care or prolonged mechanical ventilatory support

          -  Chronic pain

          -  Drug abuser

          -  Hypersensitivity reaction to aspirin or NSAIDs

          -  Refuse to enroll
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2016</study_first_submitted>
  <study_first_submitted_qc>April 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2016</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jeong-Hwa Seo</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>acute pain</keyword>
  <keyword>postoperative</keyword>
  <keyword>surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

